GrafTech Reports Third Quarter 2022 Results
GrafTech International Ltd. (NYSE: EAF) reported a net income of $93 million and EPS of $0.36 for Q3 2022, down from $120 million and $0.45 in Q3 2021. Sales fell to $304 million, reflecting an 18% decline in sales volume due to operational suspension in Monterrey, Mexico, affecting approximately 10,000-12,000 MT of orders. Adjusted EBITDA was $129 million with a margin of 42%. The company navigates inflationary pressures and geopolitical tensions that have softened demand. GrafTech is aligning expenses and pursuing options to resume operations in Monterrey.
- Adjusted EBITDA margin of 42%; cash flow from operations of $68 million.
- Increased pricing on non-LTA volume by approximately 30%.
- Successful debt repayment of $110 million in H1 2022 and $60 million spent on share repurchases.
- Net sales decreased by 13% compared to the same quarter last year.
- Sales volume down 18%, reflecting operational disruptions in Monterrey.
- Geopolitical tensions and economic uncertainty are expected to weaken demand further.
Navigating Near-term Challenges in the Operating Environment
GrafTech’s Facility in
Third Quarter 2022 Highlights
-
Net income of
$93 million
-
Earnings per share ("EPS")(1) of
and adjusted EPS(1)(2) of$0.36 $0.37
-
Adjusted EBITDA(2) of
, for a$129 million 42% adjusted EBITDA margin(3)
- Sales volume of 36 thousand metric tons ("MT")
- Production volume of 38 thousand MT
-
Cash flow from operating activities of
$68 million
CEO Comments
"Third quarter results fell short of our expectations, reflecting near-term challenges in the operating environment," said
"I am proud of our team as they are working tirelessly to navigate the current market uncertainties, while pursuing all options to ensure our operations in
Third Quarter 2022 Financial Performance |
|||||||||||||||
(dollars in thousands, except per share amounts) |
|
|
Nine Months Ended
|
||||||||||||
|
|
||||||||||||||
Q3 2022 |
Q2 2022 |
Q3 2021 |
|
2022 |
2021 |
||||||||||
Net sales |
$ |
303,840 |
$ |
363,646 |
$ |
347,348 |
|
$ |
1,033,731 |
$ |
982,495 |
||||
Net income |
$ |
93,451 |
$ |
114,997 |
$ |
119,886 |
|
$ |
332,631 |
$ |
246,850 |
||||
EPS(1) |
$ |
0.36 |
$ |
0.44 |
$ |
0.45 |
|
$ |
1.28 |
$ |
0.92 |
||||
Cash flow from operating activities |
$ |
68,166 |
$ |
60,123 |
$ |
134,256 |
|
$ |
274,605 |
$ |
343,011 |
||||
|
|
|
|
|
|
|
|||||||||
Adjusted net income(2) |
$ |
93,883 |
$ |
115,102 |
$ |
119,038 |
|
$ |
334,905 |
$ |
333,405 |
||||
Adjusted EPS(1)(2) |
$ |
0.37 |
$ |
0.44 |
$ |
0.45 |
|
$ |
1.29 |
$ |
1.25 |
||||
Adjusted EBITDA(2) |
$ |
128,567 |
$ |
158,196 |
$ |
172,175 |
|
$ |
456,363 |
$ |
487,123 |
||||
Adjusted free cash flow(4) |
$ |
52,233 |
$ |
47,630 |
$ |
125,145 |
|
$ |
229,767 |
$ |
369,303 |
Net sales for the third quarter of 2022 were
Net income for the third quarter of 2022 was
In the third quarter of 2022, cash flow from operating activities was
Operational and Commercial Update |
|||||||||||||||
Key operating metrics |
|
|
|
|
Nine Months Ended
|
||||||||||
|
|
|
|
|
|||||||||||
(in thousands, except percentages) |
Q3 2022 |
Q2 2022 |
Q3 2021 |
|
2022 |
|
2021 |
||||||||
Sales volume (MT)(6) |
35.7 |
|
42.3 |
|
43.4 |
|
|
121.3 |
|
|
123.1 |
|
|||
Production volume (MT)(7) |
37.7 |
|
43.9 |
|
39.5 |
|
|
127.7 |
|
|
119.0 |
|
|||
Total production capacity (MT)(8)(9) |
55.0 |
|
58.0 |
|
55.0 |
|
|
171.0 |
|
|
171.0 |
|
|||
Total capacity utilization(9)(10) |
69 |
% |
76 |
% |
72 |
% |
|
75 |
% |
|
70 |
% |
|||
Production capacity excluding |
48.0 |
|
51.0 |
|
48.0 |
|
|
150.0 |
|
|
150.0 |
|
|||
Capacity utilization excluding |
79 |
% |
86 |
% |
82 |
% |
|
85 |
% |
|
79 |
% |
For the third quarter of 2022, the weighted-average realized price for our LTA volume was
Production volume was 38 thousand MT in the third quarter of 2022, a decrease of
Steel market capacity utilization rates have been as follows:
|
Q3 2022 |
Q2 2022 |
Q3 2021 |
||||||
Global (ex- |
64 |
% |
69 |
% |
71 |
% |
|||
|
78 |
% |
81 |
% |
84 |
% |
The table of estimated shipments of graphite electrodes under existing LTAs has been updated as follows to reflect our current expectations(14)(15):
|
|
2022 |
|
2023 |
|
2024 |
Estimated LTA volume (in thousands of MT) |
|
88-92 |
|
26-33 |
|
12-15 |
Estimated LTA revenue (in millions) |
|
|
|
|
|
|
Update on Operations in
On
While we are complying with the suspension notice, we strongly disagree with the course of action taken by the state authorities and will continue to seek resolution, including a restart of our
Our facility in
As such, we are pursuing several alternatives with respect to production and sourcing of pin stock as well as other mitigation activities to minimize the impact on our business and our customers if the
Until operations in
Capital Structure and Capital Allocation
As of
Outlook
The current environment for the steel industry remains volatile with key markets, such as
At the same time, as is the case for nearly all industries, costs remain elevated for raw materials, energy and logistics. Due to the current inflationary environment, we anticipate sequential cost increases to continue in the fourth quarter of 2022.
In addition to the efforts to resolve the situation involving our
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings call being held on
About
________________________
(1) |
EPS represents diluted earnings per share. Adjusted EPS represents diluted adjusted earnings per share. |
|
(2) |
A non-GAAP financial measure, see below for more information and a reconciliation of EBITDA, adjusted EBITDA and adjusted net income to net income, and adjusted EPS to EPS, the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
|
(3) |
Adjusted EBITDA margin is calculated as adjusted EBITDA divided by net sales (Q3 2022 adjusted EBITDA of |
|
(4) |
A non-GAAP financial measure, see below for more information and a reconciliation of adjusted free cash flow and free cash flow to cash flow from operating activities, the most directly comparable financial measure calculated and presented in accordance with GAAP. |
|
(5) |
Adjusted free cash flow conversion is calculated as adjusted free cash flow divided by adjusted EBITDA (Q3 2022 adjusted free cash flow of |
|
(6) |
Sales volume reflects only graphite electrodes manufactured by us. |
|
(7) |
Production volume reflects graphite electrodes we produced during the period. |
|
(8) |
Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary. |
|
(9) |
Includes graphite electrode facilities in Calais, |
|
(10) |
Capacity utilization reflects production volume as a percentage of production capacity. |
|
(11) |
Our |
|
(12) |
Source: |
|
(13) |
Source: |
|
(14) |
As it relates to the conflict between |
|
(15) |
The estimates set forth in this table reflect our current expectations regarding the shift of LTA revenue out of 2022 into 2023, primarily due to the suspension of our operations in |
|
(16) |
Includes expected termination fees from a few customers that have failed to meet certain obligations under their LTAs. |
Cautionary Note Regarding Forward-Looking Statements
This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the
These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our most recent Annual Report on Form 10-K and other filings with the
Non‑GAAP Financial Measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow, and adjusted free cash flow conversion are non-GAAP financial measures.
We define EBITDA, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA as EBITDA plus any pension and other post-employment benefit ("OPEB") plan expenses, adjustments for public offerings and related expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. Adjusted EBITDA margin is also a non-GAAP financial measure used by our management and our Board of Directors as supplemental information to assess the Company’s operational performance and is calculated as adjusted EBITDA divided by net sales. In addition, we believe adjusted EBITDA, adjusted EBITDA margin and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities. We also monitor the ratio of total debt to trailing twelve month adjusted EBITDA, because we believe it is a useful and widely used way to assess our leverage.
Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses relating to our pension and OPEB plans;
- adjusted EBITDA does not reflect public offerings and related expenses;
-
adjusted EBITDA does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
U.S. dollar;
- adjusted EBITDA does not reflect stock-based compensation expense;
- adjusted EBITDA does not reflect the non‑cash write‑off of fixed assets;
- adjusted EBITDA does not reflect related party payable - Tax Receivable Agreement adjustments;
- adjusted EBITDA does not reflect Change in Control charges; and
- other companies, including companies in our industry, may calculate EBITDA, adjusted EBITDA and adjusted EBITDA margin differently, which reduces its usefulness as a comparative measure.
We define adjusted net income, a non‑GAAP financial measure, as net income or loss, excluding the items used to calculate adjusted EBITDA, less the tax effect of those adjustments. We define adjusted EPS, a non‑GAAP financial measure, as adjusted net income divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net income and adjusted EPS are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
Free cash flow and adjusted free cash flow, non-GAAP financial measures, are metrics used by our management and our Board of Directors to analyze cash flows generated from operations. We define free cash flow as net cash provided by operating activities less capital expenditures. We define adjusted free cash flow as free cash flow adjusted by payments of the Change in Control charges that were triggered as a result of the ownership of our largest stockholder falling below
In evaluating EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow and adjusted free cash flow conversion, you should be aware that in the future, we will incur expenses similar to the adjustments in the reconciliations presented below, other than the Change in Control charges. Our presentations of EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow and adjusted free cash flow conversion should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow and adjusted free cash flow conversion alongside other measures of financial performance and liquidity, including our net income, EPS and cash flow from operating activities, respectively, and other GAAP measures.
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(Dollars in thousands, except per share data) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|||||
ASSETS |
|
|
|
|||||
Current assets: |
|
|
|
|||||
Cash and cash equivalents |
$ |
109,394 |
|
|
$ |
57,514 |
|
|
Accounts and notes receivable, net of allowance for doubtful accounts of |
|
179,139 |
|
|
|
207,547 |
|
|
Inventories |
|
438,866 |
|
|
|
289,432 |
|
|
Prepaid expenses and other current assets |
|
74,344 |
|
|
|
73,364 |
|
|
Total current assets |
|
801,743 |
|
|
|
627,857 |
|
|
Property, plant and equipment |
|
815,318 |
|
|
|
815,298 |
|
|
Less: accumulated depreciation |
|
331,535 |
|
|
|
313,825 |
|
|
Net property, plant and equipment |
|
483,783 |
|
|
|
501,473 |
|
|
Deferred income taxes |
|
18,607 |
|
|
|
26,187 |
|
|
|
|
171,117 |
|
|
|
171,117 |
|
|
Other assets |
|
91,717 |
|
|
|
85,684 |
|
|
Total assets |
$ |
1,566,967 |
|
|
$ |
1,412,318 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|||||
Current liabilities: |
|
|
|
|||||
Accounts payable |
$ |
119,410 |
|
|
$ |
117,112 |
|
|
Long-term debt, current maturities |
|
113 |
|
|
|
127 |
|
|
Accrued income and other taxes |
|
38,585 |
|
|
|
57,097 |
|
|
Other accrued liabilities |
|
87,385 |
|
|
|
56,405 |
|
|
Related party payable - Tax Receivable Agreement |
|
4,481 |
|
|
|
3,828 |
|
|
Total current liabilities |
|
249,974 |
|
|
|
234,569 |
|
|
|
|
|
|
|||||
Long-term debt |
|
921,090 |
|
|
|
1,029,561 |
|
|
Other long-term obligations |
|
69,111 |
|
|
|
68,657 |
|
|
Deferred income taxes |
|
44,818 |
|
|
|
40,674 |
|
|
Related party payable - Tax Receivable Agreement long-term |
|
10,973 |
|
|
|
15,455 |
|
|
Stockholders’ equity: |
|
|
|
|||||
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
Common stock, par value |
|
2,566 |
|
|
|
2,633 |
|
|
Additional paid-in capital |
|
744,519 |
|
|
|
761,412 |
|
|
Accumulated other comprehensive loss |
|
(26,375 |
) |
|
|
(7,444 |
) |
|
Accumulated deficit |
|
(449,709 |
) |
|
|
(733,199 |
) |
|
Total stockholders’ equity |
|
271,001 |
|
|
|
23,402 |
|
|
|
|
|
|
|||||
Total liabilities and stockholders’ equity |
$ |
1,566,967 |
|
|
$ |
1,412,318 |
|
|
||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(Dollars in thousands, except per share data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
Three Months |
|
Nine Months |
|||||||||||||
Ended |
|
Ended |
||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||
|
|
|
|
|
|
|
|
|||||||||
Net sales |
$ |
303,840 |
|
|
$ |
347,348 |
|
|
$ |
1,033,731 |
|
|
$ |
982,495 |
|
|
Cost of sales |
|
170,171 |
|
|
|
170,286 |
|
|
|
562,881 |
|
|
|
518,549 |
|
|
Gross profit |
|
133,669 |
|
|
|
177,062 |
|
|
|
470,850 |
|
|
|
463,946 |
|
|
Research and development |
|
1,014 |
|
|
|
983 |
|
|
|
2,617 |
|
|
|
2,970 |
|
|
Selling and administrative expenses |
|
18,578 |
|
|
|
19,006 |
|
|
|
57,862 |
|
|
|
114,942 |
|
|
Operating income |
|
114,077 |
|
|
|
157,073 |
|
|
|
410,371 |
|
|
|
346,034 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Other income, net |
|
(598 |
) |
|
|
(364 |
) |
|
|
(1,358 |
) |
|
|
(314 |
) |
|
Interest expense |
|
6,424 |
|
|
|
16,048 |
|
|
|
25,035 |
|
|
|
54,209 |
|
|
Interest income |
|
(241 |
) |
|
|
(417 |
) |
|
|
(2,197 |
) |
|
|
(653 |
) |
|
Income before provision for income taxes |
|
108,492 |
|
|
|
141,806 |
|
|
|
388,891 |
|
|
|
292,792 |
|
|
Provision for income taxes |
|
15,041 |
|
|
|
21,920 |
|
|
|
56,260 |
|
|
|
45,942 |
|
|
Net income |
$ |
93,451 |
|
|
$ |
119,886 |
|
|
$ |
332,631 |
|
|
$ |
246,850 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Basic income per common share: |
|
|
|
|
|
|
|
|||||||||
Net income per share |
$ |
0.36 |
|
|
$ |
0.45 |
|
|
$ |
1.28 |
|
|
$ |
0.92 |
|
|
Weighted average common shares outstanding |
|
256,848,575 |
|
|
|
267,106,109 |
|
|
|
259,415,295 |
|
|
|
267,327,888 |
|
|
Diluted income per common share: |
|
|
|
|
|
|
|
|||||||||
Net income per share |
$ |
0.36 |
|
|
$ |
0.45 |
|
|
$ |
1.28 |
|
|
$ |
0.92 |
|
|
Weighted average common shares outstanding |
|
256,853,454 |
|
|
|
267,178,963 |
|
|
|
259,424,885 |
|
|
|
267,441,394 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||||||||||
(Dollars in thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
Three Months |
|
Nine Months |
|||||||||||||
Ended |
|
Ended |
||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||
Cash flow from operating activities: |
|
|
|
|
|
|
|
|||||||||
Net income |
$ |
93,451 |
|
|
$ |
119,886 |
|
|
$ |
332,631 |
|
|
$ |
246,850 |
|
|
Adjustments to reconcile net income to cash provided by operations: |
|
|
|
|
|
|
|
|||||||||
Depreciation and amortization |
|
13,262 |
|
|
|
15,584 |
|
|
|
41,708 |
|
|
|
48,415 |
|
|
Deferred income tax provision |
|
4,659 |
|
|
|
(1,985 |
) |
|
|
11,216 |
|
|
|
(6,180 |
) |
|
Non-cash stock-based compensation expense |
|
628 |
|
|
|
262 |
|
|
|
1,666 |
|
|
|
16,293 |
|
|
Non-cash interest expense |
|
571 |
|
|
|
2,551 |
|
|
|
(3,103 |
) |
|
|
9,750 |
|
|
Other adjustments |
|
(3,181 |
) |
|
|
3,430 |
|
|
|
230 |
|
|
|
6,784 |
|
|
Net change in working capital* |
|
(39,633 |
) |
|
|
(3,260 |
) |
|
|
(101,622 |
) |
|
|
47,174 |
|
|
Change in related party Tax Receivable Agreement |
|
— |
|
|
|
— |
|
|
|
(3,828 |
) |
|
|
(21,752 |
) |
|
Change in long-term assets and liabilities |
|
(1,591 |
) |
|
|
(2,212 |
) |
|
|
(4,293 |
) |
|
|
(4,323 |
) |
|
Net cash provided by operating activities |
|
68,166 |
|
|
|
134,256 |
|
|
|
274,605 |
|
|
|
343,011 |
|
|
Cash flow from investing activities: |
|
|
|
|
|
|
|
|||||||||
Capital expenditures |
|
(15,933 |
) |
|
|
(14,374 |
) |
|
|
(45,281 |
) |
|
|
(40,426 |
) |
|
Proceeds from the sale of fixed assets |
|
22 |
|
|
|
137 |
|
|
|
161 |
|
|
|
356 |
|
|
Net cash used in investing activities |
|
(15,911 |
) |
|
|
(14,237 |
) |
|
|
(45,120 |
) |
|
|
(40,070 |
) |
|
Cash flow from financing activities: |
|
|
|
|
|
|
|
|||||||||
Debt issuance and modification costs |
|
— |
|
|
|
(25 |
) |
|
|
(2,232 |
) |
|
|
(3,109 |
) |
|
Principal payments on long-term debt |
|
— |
|
|
|
(100,000 |
) |
|
|
(110,000 |
) |
|
|
(300,000 |
) |
|
Repurchase of common stock - non-related party |
|
— |
|
|
|
(42,378 |
) |
|
|
(60,000 |
) |
|
|
(42,378 |
) |
|
Payments for taxes related to net share settlement of equity awards |
|
— |
|
|
|
— |
|
|
|
(230 |
) |
|
|
(4,074 |
) |
|
Proceeds from exercise of stock options |
|
— |
|
|
|
— |
|
|
|
225 |
|
|
|
— |
|
|
Dividends paid to non-related party |
|
(1,926 |
) |
|
|
(2,028 |
) |
|
|
(5,843 |
) |
|
|
(5,446 |
) |
|
Dividends paid to related party |
|
(640 |
) |
|
|
(640 |
) |
|
|
(1,919 |
) |
|
|
(2,567 |
) |
|
Interest rate swap settlements |
|
5,195 |
|
|
|
(1,155 |
) |
|
|
3,762 |
|
|
|
(3,264 |
) |
|
Net cash provided by (used in) financing activities |
|
2,629 |
|
|
|
(146,226 |
) |
|
|
(176,237 |
) |
|
|
(360,838 |
) |
|
Net change in cash and cash equivalents |
|
54,884 |
|
|
|
(26,207 |
) |
|
|
53,248 |
|
|
|
(57,897 |
) |
|
Effect of exchange rate changes on cash and cash equivalents |
|
(1,325 |
) |
|
|
(1,268 |
) |
|
|
(1,368 |
) |
|
|
(889 |
) |
|
Cash and cash equivalents at beginning of period |
|
55,835 |
|
|
|
114,131 |
|
|
|
57,514 |
|
|
|
145,442 |
|
|
Cash and cash equivalents at end of period |
$ |
109,394 |
|
|
$ |
86,656 |
|
|
$ |
109,394 |
|
|
$ |
86,656 |
|
|
|
|
|
|
|
|
|
|
|||||||||
* Net change in working capital due to changes in the following components: |
|
|
|
|
|
|
||||||||||
Accounts and notes receivable, net |
$ |
23,348 |
|
|
$ |
(12,760 |
) |
|
$ |
22,229 |
|
|
$ |
(3,455 |
) |
|
Inventories |
|
(41,784 |
) |
|
|
(15,069 |
) |
|
|
(146,501 |
) |
|
|
(7,246 |
) |
|
Prepaid expenses and other current assets |
|
15,718 |
|
|
|
(5,593 |
) |
|
|
1,690 |
|
|
|
(17,664 |
) |
|
Income taxes payable |
|
(3,790 |
) |
|
|
15,390 |
|
|
|
(20,226 |
) |
|
|
(2,371 |
) |
|
Accounts payable and accruals |
|
(39,013 |
) |
|
|
9,000 |
|
|
|
35,373 |
|
|
|
71,748 |
|
|
Interest payable |
|
5,888 |
|
|
|
5,772 |
|
|
|
5,813 |
|
|
|
6,162 |
|
|
Net change in working capital |
$ |
(39,633 |
) |
|
$ |
(3,260 |
) |
|
$ |
(101,622 |
) |
|
$ |
47,174 |
|
NON-GAAP RECONCILIATION |
|||||||||||||||||||
(Dollars in thousands, except per share data) |
|||||||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
|||||||||||||||||||
Reconciliation of Net Income to Adjusted Net Income |
|
|
|
||||||||||||||||
|
|
|
|
Nine Months |
|||||||||||||||
Ended |
|||||||||||||||||||
|
Q3 2022 |
Q2 2022 |
Q3 2021 |
2022 |
2021 |
||||||||||||||
|
|
|
|
|
|
||||||||||||||
Net income |
$ |
93,451 |
|
$ |
114,997 |
|
$ |
119,886 |
|
$ |
332,631 |
|
$ |
246,850 |
|||||
|
|
|
|
|
|
||||||||||||||
Diluted income per common share: |
|
|
|
|
|
||||||||||||||
Net income per share |
$ |
0.36 |
|
$ |
0.44 |
|
$ |
0.45 |
|
$ |
1.28 |
|
$ |
0.92 |
|||||
Weighted average shares outstanding |
|
256,853,454 |
|
|
258,845,588 |
|
|
267,178,963 |
|
|
259,424,885 |
|
|
267,441,394 |
|||||
|
|
|
|
|
|
||||||||||||||
Adjustments, pre-tax: |
|
|
|
|
|
||||||||||||||
Pension and OPEB plan expenses(1) |
|
534 |
|
|
553 |
|
|
434 |
|
|
1,638 |
|
|
1,295 |
|||||
Public offerings and related expenses(2) |
|
— |
|
|
100 |
|
|
— |
|
|
100 |
|
|
663 |
|||||
Non-cash (gains) losses on foreign currency remeasurement(3) |
|
(532 |
) |
|
(1,002 |
) |
|
(1,542 |
) |
|
(298 |
) |
|
365 |
|||||
Stock-based compensation expense(4) |
|
628 |
|
|
573 |
|
|
262 |
|
|
1,666 |
|
|
1,580 |
|||||
Non-cash fixed asset write-off (5) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
313 |
|||||
Related party payable - Tax Receivable Agreement adjustment(6) |
|
— |
|
|
— |
|
|
— |
|
|
(180 |
) |
|
47 |
|||||
Change in Control LTIP award(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
73,384 |
|||||
Change in Control stock-based compensation acceleration(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
14,713 |
|||||
Total non-GAAP adjustments pre-tax |
|
630 |
|
|
224 |
|
|
(846 |
) |
|
2,926 |
|
|
92,360 |
|||||
Income tax impact on non-GAAP adjustments(8) |
|
198 |
|
|
119 |
|
|
2 |
|
|
652 |
|
|
5,805 |
|||||
Adjusted net income |
$ |
93,883 |
|
$ |
115,102 |
|
$ |
119,038 |
|
$ |
334,905 |
|
$ |
333,405 |
(1) |
Net periodic benefit cost for our pension and OPEB plans. |
(2) |
Legal, accounting, printing and registration fees associated with the public offerings and related expenses. |
(3) |
Non-cash (gains) losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
(4) |
Non-cash expense for stock-based compensation grants. |
(5) |
Non-cash write-off of fixed assets. |
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
(8) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
NON-GAAP RECONCILIATION | |||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
|||||||||||||||
Reconciliation of EPS to Adjusted EPS |
|
|
|
||||||||||||
|
|
|
|
Nine Months |
|||||||||||
Ended |
|||||||||||||||
|
Q3 2022 |
Q2 2022 |
Q3 2021 |
2022 |
2021 |
||||||||||
|
|
|
|
|
|
||||||||||
EPS |
$ |
0.36 |
$ |
0.44 |
$ |
0.45 |
$ |
1.28 |
$ |
0.92 |
|||||
Adjustments per share: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses(1) |
|
— |
|
— |
|
— |
|
— |
|
— |
|||||
Public offerings and related expenses(2) |
|
— |
|
— |
|
— |
|
— |
|
— |
|||||
Non-cash (gains) losses on foreign currency remeasurement(3) |
|
— |
|
— |
|
— |
|
— |
|
— |
|||||
Stock-based compensation expense(4) |
|
0.01 |
|
— |
|
— |
|
0.01 |
|
0.02 |
|||||
Non-cash fixed asset write-off (5) |
|
— |
|
— |
|
— |
|
— |
|
— |
|||||
Related party payable - Tax Receivable Agreement adjustment(6) |
|
— |
|
— |
|
— |
|
— |
|
— |
|||||
Change in Control LTIP award(7) |
|
— |
|
— |
|
— |
|
— |
|
0.27 |
|||||
Change in Control stock-based compensation acceleration(7) |
|
— |
|
— |
|
— |
|
— |
|
0.06 |
|||||
Total non-GAAP adjustments pre-tax per share |
|
0.01 |
|
— |
|
— |
|
0.01 |
|
0.35 |
|||||
Income tax impact on non-GAAP adjustments per share(8) |
|
— |
|
— |
|
— |
|
— |
|
0.02 |
|||||
Adjusted EPS |
$ |
0.37 |
$ |
0.44 |
$ |
0.45 |
$ |
1.29 |
$ |
1.25 |
(1) |
Net periodic benefit cost for our pension and OPEB plans. |
(2) |
Legal, accounting, printing and registration fees associated with the public offerings and related expenses. |
(3) |
Non-cash (gains) losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
(4) |
Non-cash expense for stock-based compensation grants. |
(5) |
Non-cash write-off of fixed assets. |
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
(8) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
NON-GAAP RECONCILIATION | ||||||||||||||||||||
(Dollars in thousands) |
||||||||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
||||||||||||||||||||
Reconciliation of Net Income to Adjusted EBITDA |
|
|
|
|||||||||||||||||
|
|
|
|
Nine Months |
||||||||||||||||
Ended |
||||||||||||||||||||
|
Q3 2022 |
Q2 2022 |
Q3 2021 |
2022 |
2021 |
|||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Net income |
$ |
93,451 |
|
$ |
114,997 |
|
$ |
119,886 |
|
$ |
332,631 |
|
$ |
246,850 |
|
|||||
Add: |
|
|
|
|
|
|||||||||||||||
Depreciation and amortization |
|
13,262 |
|
|
14,012 |
|
|
15,584 |
|
|
41,708 |
|
|
48,415 |
|
|||||
Interest expense |
|
6,424 |
|
|
9,399 |
|
|
16,048 |
|
|
25,035 |
|
|
54,209 |
|
|||||
Interest income |
|
(241 |
) |
|
(1,858 |
) |
|
(417 |
) |
|
(2,197 |
) |
|
(653 |
) |
|||||
Income taxes |
|
15,041 |
|
|
21,422 |
|
|
21,920 |
|
|
56,260 |
|
|
45,942 |
|
|||||
EBITDA |
|
127,937 |
|
|
157,972 |
|
|
173,021 |
|
|
453,437 |
|
|
394,763 |
|
|||||
Adjustments: |
|
|
|
|
|
|||||||||||||||
Pension and OPEB plan expenses(1) |
|
534 |
|
|
553 |
|
|
434 |
|
|
1,638 |
|
|
1,295 |
|
|||||
Public offerings and related expenses(2) |
|
— |
|
|
100 |
|
|
— |
|
|
100 |
|
|
663 |
|
|||||
Non-cash (gains) losses on foreign currency remeasurement(3) |
|
(532 |
) |
|
(1,002 |
) |
|
(1,542 |
) |
|
(298 |
) |
|
365 |
|
|||||
Stock-based compensation expense(4) |
|
628 |
|
|
573 |
|
|
262 |
|
|
1,666 |
|
|
1,580 |
|
|||||
Non-cash fixed asset write-off (5) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
313 |
|
|||||
Related party payable - Tax Receivable Agreement adjustment(6) |
|
— |
|
|
— |
|
|
— |
|
|
(180 |
) |
|
47 |
|
|||||
Change in Control LTIP award(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
73,384 |
|
|||||
Change in Control stock-based compensation acceleration(7) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
14,713 |
|
|||||
Adjusted EBITDA |
$ |
128,567 |
|
$ |
158,196 |
|
$ |
172,175 |
|
$ |
456,363 |
|
$ |
487,123 |
|
|||||
|
|
|
|
|
|
(1) |
|
Net periodic benefit cost for our pension and OPEB plans. |
(2) |
|
Legal, accounting, printing and registration fees associated with the public offerings and related expenses. |
(3) |
|
Non-cash (gains) losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
(4) |
|
Non-cash expense for stock-based compensation grants. |
(5) |
|
Non-cash write-off of fixed assets. |
(6) |
|
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
(7) |
|
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
NON-GAAP RECONCILIATION |
||||||||||||||||||||
(Dollars in thousands) |
||||||||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
||||||||||||||||||||
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow and Adjusted Free Cash Flow |
|
|
|
|||||||||||||||||
|
|
|
|
Nine Months Ended |
||||||||||||||||
|
||||||||||||||||||||
|
Q3 2022 |
Q2 2022 |
Q3 2021 |
2022 |
|
2021 |
||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
Net cash provided by operating activities |
$ |
68,166 |
|
$ |
60,123 |
|
$ |
134,256 |
|
$ |
274,605 |
|
|
$ |
343,011 |
|
||||
Capital expenditures |
|
(15,933 |
) |
|
(12,493 |
) |
|
(14,374 |
) |
|
(45,281 |
) |
|
|
(40,426 |
) |
||||
Free cash flow |
|
52,233 |
|
|
47,630 |
|
|
119,882 |
|
|
229,324 |
|
|
|
302,585 |
|
||||
|
|
|
|
|
|
|
||||||||||||||
Change in Control payment(1) |
|
— |
|
|
— |
|
|
5,263 |
|
|
443 |
|
|
|
66,718 |
|
||||
Adjusted free cash flow |
$ |
52,233 |
|
$ |
47,630 |
|
$ |
125,145 |
|
$ |
229,767 |
|
|
$ |
369,303 |
|
(1) |
In the second quarter of 2021, we incurred pre-tax Change in Control charges of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221103006081/en/
216-676-2000
investor.relations@graftech.com
Source:
FAQ
What were GrafTech's Q3 2022 financial highlights?
How did the Monterrey operations impact GrafTech's performance?
What factors contributed to the decrease in GrafTech's sales in Q3 2022?